Desert Control Releases Q3 2024 Report and Year-to-Date Company Update

Sandnes, Norway, 15 November 2024 — Desert Control AS (DSRT) announces its third-quarter report and interim financial results for the fiscal period ending 30 September 2024. Desert Control continued its positive momentum in the third quarter of 2024, achieving

Sammanhang: ...The quarter saw strong results from pilots in agriculture and landscaping, supporting negotiations for larger commercial projects in the United States. Growing traction in the Middle East further strengthens the foundation for sustainable growth under the company’s royalty-based licensed operator model....

Omnämnda platser: Norway. Omnämnda personer: Desert Control AS, Desert Control Releases, Company Update Sandnes.

Hamlet BioPharma receives U.S. FDA Fast Track designation for Alpha 1H for the treatment of non-muscle invasive bladder cancer

Lund, Sweden, November 29, 2023. Hamlet BioPharma AB (publ), the pharmaceutical company with a strong portfolio of projects for the treatment of cancer and infections, announces today that the U.S. Food and Drug Administration (FDA) has granted Fast Track

Sammanhang: ...Hamlet BioPharma AB (publ), the pharmaceutical company with a strong portfolio of projects for the treatment of cancer and infections, announces today that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation for its drug candidate Alpha1H for the treatment of non-muscle invasive bladder cancer. ...

Omnämnda platser: Lund, Sweden. Omnämnda personer: Hamlet BioPharma, Hamlet BioPharma AB.